"There is a growing acceptance of mining in Ecuador and a greater understanding of what responsible mining means in terms of generating benefits like tax revenues and jobs while still protecting the environment."
"The day will come when most of the copper produced in Peru will be beneficiated in the country, and to be able to trade it internationally, it will have to be processed with renewable energy."
"Major players like BHP and Rio Tinto are evaluating new assets in Brazil, particularly in base metals and lithium. We believe investments will increase over the next 12 months."
PRESIDENT, CÁMARA MINERA DE PANAMÁ (CAMIPA) & CEO, CONSULTORES AMBIENTALES Y MULTISERVICIOS S.A. (CAMSA)
"The shutdown of Cobre created a major economic void. This single project represented 4.8% of Panama's GDP (surpassing the Panama Canal’s 3.5% contribution) and 76% of the country’s exports."
VP OPERATIONS AND SALES AMERICAS, ENERGOLD DRILLING
"Because our rigs are modular, they can be easily transportable using ATVs, canoes, helicopters, or even by hand, whereas conventional rigs need to be transported via large trucks."
"Cañariaco is a resource capable of producing 150,000 to 160,000 t/y of copper — there are not many that have that potential, and fewer still with the major backing we already have."
GERENTE GENERAL, INTI MINING SMART SOLUTIONS (IMSS)
“Antes, el consultor proponía, la ingeniería cuestionaba y el proveedor ajustaba. Hoy entendemos que la integración desde el inicio no es un ideal, sino una necesidad.”
“En Perú la regulación está más orientada al sector de obras públicas, como la ampliación de carreteras, dejando un vacío para los proyectos privados que requieren reasentar poblaciones.”
"While projects eventually come to an end, the real legacy lies in the training, development and skills transfer they leave behind. This enables local workforces to replicate the work, empowering communities and strengthening local expertise."
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.